Form 4: LeMaitre Vascular CFO Reports Stock Transactions Following Vesting of Restricted Stock Units

LeMaitre Vascular's Chief Financial Officer, Joseph P. Pellegrino Jr., reported the acquisition of shares through dividend equivalent rights and the disposal of shares to cover tax obligations related to vested restricted stock units.

Summary

• Joseph P. Pellegrino Jr., the Chief Financial Officer of LeMaitre Vascular, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On December 9, 2024, Mr. Pellegrino acquired 4 shares of common stock through the release of dividend equivalent rights.
• Also on December 9, 2024, he disposed of 255 shares of common stock at a price of $101.12 per share to satisfy tax withholding obligations.
• These transactions occurred in connection with the vesting of restricted stock units awarded to Mr. Pellegrino on December 8, 2023.
• Following these transactions, Mr. Pellegrino beneficially owns 10,081 shares of LeMaitre Vascular common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as the transactions are routine and related to compensation. The acquisition of shares through dividend rights is a positive sign, while the sale for tax purposes is a standard practice.

Positives

• The acquisition of shares through dividend equivalent rights increases the CFO's stake in the company.

Negatives

• The disposal of 255 shares, while for tax purposes, slightly reduces the CFO's direct holdings.

Risks

• There are no significant risks identified in this document, as the transactions are routine and related to compensation.

Industry Context

This filing is a standard disclosure of insider transactions, which is common in the medical device industry where stock-based compensation is often used.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies, including those in the medical device sector like Medtronic, Boston Scientific, and Abbott.
• The transactions reported are typical for executives receiving stock-based compensation, where shares are often sold to cover tax liabilities upon vesting.
• The price of $101.12 per share is a specific data point for this transaction, but it would need to be compared to the broader market and LeMaitre's historical trading data to assess its significance.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine insider activity related to compensation.
• The transactions do not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Form 4, Beneficial Ownership, LeMaitre Vascular, Stock Transactions, Dividend Equivalent Rights, Restricted Stock Units, Tax Withholding, Insider Trading